Study on the Chelate Formation and the Ion-association of Anionic Chelate of Molybdenum(VI) with 3,5-Dinitrocatechol and Monotetrazolium Cation.

The equilibria of the chelate formation and ion-association in the liquid-liquid extraction system Mo(VI)‒3,5-DNC‒INT‒H2O‒CHCl3 were studied by spectrophotometry. The optimum conditions for the chelate formation and extraction of the ion-associated complex formed between the anionic chelate of Mo(VI)‒3,5-dinitrocatechol (3,5-DNC) and the cation of 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT) were established. The validity of Beer's law was checked and some analytical characteristics were calculated.

Study on the Complex Equilibria of Molybdenum(VI) with 3,5-Dinitrocatechol and Ditetrazolium Salt.

The complex formed between an anionic chelate of Mo(VI)-3,5-dinitrocatechol (3,5-DNC) with the cation of 3,3'-(3,3'-dimethoxy-4,4'-biphenylene)bis(2,5-diphenyl-2H-tetrazolium chloride) (Blue Tetrazolium Chloride, BTC) in the liquid-liquid extraction system Mo(VI)-3,5-DNC-BTC-H2O-CHCl3 was studied. The optimum conditions for the complex formation and extraction of the ion-associated complex were established by spectrophotometry. The molar ratio of the reagents was determined by independent methods.

Pharmacokinetics and comparative bioavailability of two metformin formulations after single-dose administration in healthy subjects.

Objective: To assess the average bioequivalence of two formulations of metformin after single-dose administration of each treatment to healthy subjects under fasting conditions by assessing the pharmacokinetic measures of systemic exposure and evaluating the confidence intervals (CIs) for each pharmacokinetic parameter.

Design: Randomised, comparative, single-dose, open-label, balanced, two-period, two-treatment, crossover study under fasting conditions.

Participants: 20 healthy volunteers (ten men and ten women) took part in the study.

Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.

Objective: To explore the ability of the nonparametric expectation maximisation (NPEM) method of population pharmacokinetic modelling to deal with sparse data in estimating systemic caffeine clearance for monitoring and evaluation of cytochrome P450 (CYP) 1A2 activity.

Design And Participants: Nonblind, single-dose clinical investigation in 34 non-related adult Bulgarian Caucasians (18 women and 16 men, aged between 18 and 62 years) with normal and reduced renal function.

Methods: Each participant received oral caffeine 3 mg/kg.